Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01168_DB06700_nanopub.RA_-l4gp6m9yYkiI425hc1j3v2O8JmCjmwWiYvGdpG6bQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01168_DB06700 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01168_DB06700 label "DDI between Procarbazine and Desvenlafaxine - Increased risk of serotonin syndrome. Ensure adequate washout period between therapies to avoid toxicity. Concurrent therapy should be avoided. [drugbank_resource:DB01168_DB06700]" assertion.
- drugbank_resource:DB01168_DB06700 identifier "drugbank_resource:DB01168_DB06700" assertion.
- drugbank_resource:DB01168_DB06700 title "DDI between Procarbazine and Desvenlafaxine - Increased risk of serotonin syndrome. Ensure adequate washout period between therapies to avoid toxicity. Concurrent therapy should be avoided." assertion.
- drugbank:DB01168 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01168_DB06700 assertion.
- drugbank:DB06700 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01168_DB06700 assertion.